Literature DB >> 434637

The Vermont epidemic of Legionnaires' disease.

C V Broome, S A Goings, S B Thacker, R L Vogt, H N Beaty, D W Fraser.   

Abstract

Sixty-nine laboratory-documented cases of Legionnaires' disease occurred in Vermont between 1 May and 31 December 1977. Clinical manifestations were similar to those in the 1976 Philadelphia epidemic. Case-control studies suggested that Legionnaires' disease patients were more likely to present with headache or diarrhea than were patients with pneumonia of presumed nonbacterial cause. The case-fatality ratio for patients treated with erythromycin was 4%, compared with 17% in patients not treated with erythromycin. Thirteen patients had been hospitalized throughout the 10 days preceding onset of illness, equaling the maximal known incubation period. This suggests either acquisition or reactivation of infection in the hospital. However, even during the week of peak disease activity, cases occurred in patients with no recent hospital contact. The only community factor possibly associated with acquisition was home air conditioning. This prevalence of seroreactivity to the Legionnaires' disease bacterium in various community populations was as high as 26%, suggesting a possible endemic area.

Entities:  

Mesh:

Year:  1979        PMID: 434637     DOI: 10.7326/0003-4819-90-4-573

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Seroprevalence of Legionella in Shanxi Province, China.

Authors:  J Wang; M S Brown-Schlumpf; A Brown; X Z Xie
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 2.  Legionnaires disease: historical perspective.

Authors:  W C Winn
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Factors influencing the reactivity of Legionella antigens in immunofluorescence tests.

Authors:  R F Benson; G B Malcolm; L Pine; W K Harrell
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

4.  Legionnaires' disease in New York City, August-September 1978.

Authors:  L G Cordes; W D Goldman; J S Marr; S M Friedman; J D Band; E O Rothschild; H Kravitz; J C Feeley; D W Fraser
Journal:  Bull N Y Acad Med       Date:  1980-06

5.  Indirect immunofluorescence antibodies to Legionella pneumophila: frequency in a rural community.

Authors:  C M Helms; E D Renner; J P Viner; W J Hierholzer; L A Wintermeyer; W Johnson
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

Review 6.  Legionellosis.

Authors:  J A Blackmon; F W Chandler; W B Cherry; A C England; J C Feeley; M D Hicklin; R M McKinney; H W Wilkinson
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

7.  Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera.

Authors:  H W Wilkinson; D D Cruce; C V Broome
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

8.  Prevalence of antibodies in response to Legionella species, analysis of a healthy population from Jeollanam-do Province, Korea.

Authors:  Hae Kyung Lee; Mi Kyeong Woo; Yong In Ju; Soo Jin Baek; Hyeon Je Song; Jin Su Choi; Sun Seog Kweon; Doo Young Jeon; Yeon Ho Kang
Journal:  J Microbiol       Date:  2008-06-11       Impact factor: 3.422

9.  An outbreak of community-acquired Legionnaires' disease pneumonia.

Authors:  C M Helms; L A Wintermeyer; R R Zeitler; R E Larew; R M Massanari; N H Hall; W J Hausler; W Johnson
Journal:  Am J Public Health       Date:  1984-08       Impact factor: 9.308

10.  Survival of virulent Legionella pneumophila in aerosols.

Authors:  P Hambleton; M G Broster; P J Dennis; R Henstridge; R Fitzgeorge; J W Conlan
Journal:  J Hyg (Lond)       Date:  1983-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.